The EXT1 Gene Chondrosarcoma Familial Genetic Test is a specialized diagnostic procedure designed to identify mutations in the EXT1 gene, which are associated with an increased risk of developing chondrosarcoma, a type of cancer that forms in cartilage tissue. This test is particularly relevant for individuals with a family history of chondrosarcoma, as it can provide valuable insights into their genetic predisposition to this condition. By detecting mutations in the EXT1 gene, healthcare providers can offer targeted surveillance and management strategies to those at risk, potentially improving outcomes through early detection and intervention.
The test is conducted at DNA Labs UAE, a leading facility in genetic testing and analysis, ensuring high standards of accuracy and reliability. The cost of the EXT1 Gene Chondrosarcoma Familial Genetic Test is 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. Individuals considering this test are advised to discuss its implications with their healthcare provider or a genetic counselor to fully understand its benefits and limitations in the context of their personal health and family history.
The RUNX2 Gene Cleidocranial Dysplasia Genetic Test is a specialized diagnostic tool available at DNA Labs UAE, designed to identify mutations in the RUNX2 gene, which are associated with Cleidocranial Dysplasia (CCD). CCD is a rare genetic disorder characterized by abnormal development of the bones and teeth, notably delayed closure of the cranial sutures, underdeveloped or absent clavicles, and dental abnormalities. The RUNX2 gene plays a critical role in the development and differentiation of osteoblasts, the cells responsible for bone formation.
This genetic test is crucial for individuals showing symptoms of CCD or those with a family history of the condition, as it provides definitive genetic evidence of the disorder. Early diagnosis through genetic testing can guide appropriate management and treatment strategies, improving the quality of life for affected individuals.
The test is conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing services. The cost of the RUNX2 Gene Cleidocranial Dysplasia Genetic Test is 4400 AED. The price reflects the comprehensive analysis involved in detecting mutations within the RUNX2 gene and the expertise required to interpret the results accurately. For families and individuals undergoing this test, the information provided can be invaluable for making informed health and lifestyle decisions.
The "NLRP12 Gene Cold Autoinflammatory Syndrome Type 2 Genetic Test" is a specialized diagnostic procedure offered by DNA Labs UAE, designed to detect mutations in the NLRP12 gene. These mutations are associated with Cold Autoinflammatory Syndrome Type 2, a rare genetic disorder characterized by episodes of fever, skin rashes, and joint pain triggered by cold temperatures. The test involves analyzing the patient's DNA to identify any genetic alterations in the NLRP12 gene that may lead to the condition. This test is crucial for the accurate diagnosis and management of the syndrome, allowing for targeted treatment strategies to alleviate symptoms and improve the quality of life for affected individuals. The cost of the test is 4400 AED, reflecting the specialized nature of the analysis and the expertise required to interpret the results accurately. DNA Labs UAE is equipped with state-of-the-art technology and staffed by experts in genetic diagnostics, ensuring reliable and precise outcomes for patients undergoing this test.
The WISP3 gene arthropathy, also known as Progressive Pseudorheumatoid Dysplasia (PPD) or Progressive Pseudorheumatoid Arthropathy of Childhood, is a rare genetic disorder characterized by the progressive deterioration of articular cartilage, leading to joint stiffness, pain, and swelling. Unlike juvenile idiopathic arthritis, PPD does not involve autoimmune inflammation. Instead, it is caused by mutations in the WISP3 gene, which is crucial for the health and maintenance of cartilage tissue.
To diagnose this condition, genetic testing is essential. DNA Labs UAE offers a specialized genetic test aimed at detecting mutations in the WISP3 gene. This test is crucial for confirming the diagnosis of PPD, distinguishing it from other forms of juvenile arthritis, and guiding treatment and management plans.
The cost of the WISP3 gene arthropathy genetic test at DNA Labs UAE is 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory for the presence of specific mutations in the WISP3 gene. Results from this test can provide valuable information for affected individuals and their families, including the confirmation of the diagnosis, prognosis, and the possibility of genetic counseling for future family planning.
The FLNB Gene Atelosteogenesis Type 1 Genetic Test is a specialized diagnostic tool designed to identify mutations in the FLNB gene, which are responsible for Atelosteogenesis Type 1, a rare skeletal disorder. This condition is characterized by severe bone abnormalities, including poorly developed bones in the spine, ribcage, and limbs, leading to significant physical deformities and, in many cases, prenatal or early postnatal fatality. The test involves analyzing the patient's DNA to detect mutations in the FLNB gene that signal the presence of Atelosteogenesis Type 1, providing crucial information for diagnosis, management, and genetic counseling.
Conducted at DNA Labs UAE, a leading facility in genetic testing, the FLNB Gene Atelosteogenesis Type 1 Genetic Test is priced at 4400 AED. This cost reflects the sophisticated technology and expertise required to accurately identify the specific genetic mutations associated with this condition. For families with a history of skeletal disorders or for individuals showing symptoms related to Atelosteogenesis Type 1, this test offers a vital resource for confirming the diagnosis, understanding the risk of recurrence in future pregnancies, and exploring potential treatment or management options.
Atelosteogenesis Type 3 is a rare genetic disorder that affects skeletal development, leading to bone abnormalities and other significant health issues. The condition is caused by mutations in the FLNB gene, which plays a crucial role in the development and maintenance of the skeletal system. To diagnose this condition accurately, genetic testing for the FLNB gene mutation is essential.
DNA Labs UAE offers a specialized genetic test for Atelosteogenesis Type 3, focusing on identifying mutations in the FLNB gene. This test is crucial for confirming the diagnosis, understanding the risk of recurrence in a family, and guiding medical management and genetic counseling for affected families.
The cost of the FLNB gene test for Atelosteogenesis Type 3 at DNA Labs UAE is 4400 AED. This comprehensive test is conducted with high accuracy and sensitivity, ensuring reliable results for patients and their families. By choosing DNA Labs UAE for this genetic testing, individuals can expect professional service, confidentiality, and support throughout the testing process.
The HR Gene Atrichia with Papular Lesions Genetic Test is a specialized diagnostic tool offered by DNA Labs UAE, designed to identify mutations in the HR (Hairless) gene, which are linked to the rare condition known as Atrichia with Papular Lesions (APL). APL is characterized by the complete loss of hair shortly after birth and the development of papular lesions on the skin. The test plays a crucial role in confirming the diagnosis, enabling appropriate management and genetic counseling for affected individuals and their families. Priced at 4400 AED, this genetic test involves analyzing the patient's DNA to look for specific mutations in the HR gene, providing valuable insights into the condition and facilitating personalized treatment strategies.
The "IFNGR2 Gene Atypical Mycobacterial Infection Genetic Test" is a specialized diagnostic tool used to identify mutations in the IFNGR2 gene, which are associated with an increased susceptibility to atypical mycobacterial infections. These infections are caused by non-tuberculous mycobacteria (NTM) and can lead to a range of clinical manifestations, from localized skin infections to severe, disseminated disease, especially in individuals with underlying immune deficiencies.
The IFNGR2 gene plays a crucial role in the immune response to mycobacteria by encoding a component of the interferon-gamma receptor. This receptor is essential for the activation of macrophages and the subsequent killing of mycobacteria. Mutations in the IFNGR2 gene can impair this pathway, leading to an inability to effectively control mycobacterial infections.
Conducted at DNA Labs UAE, the test involves collecting a DNA sample, usually through a blood draw, and analyzing the genetic material for specific mutations in the IFNGR2 gene. The cost of the test is 4400 AED. Identifying these mutations can be crucial for the early diagnosis and management of atypical mycobacterial infections, allowing for targeted therapeutic interventions and, in some cases, prophylactic measures to prevent infection. This genetic test is particularly important for individuals with a history of recurrent or severe mycobacterial infections or those with a family history suggestive of a genetic predisposition to such infections.
The IKBKG gene atypical mycobacterial infection genetic test is a specialized diagnostic procedure designed to identify mutations in the IKBKG gene, which are linked to an increased susceptibility to atypical mycobacterial infections. These infections are caused by a type of bacteria that does not belong to the tuberculosis or leprosy organisms and can lead to a range of health issues, particularly in individuals with compromised immune systems.
This genetic test is crucial for individuals who have a history of unusual or severe mycobacterial infections, as it helps in understanding the underlying genetic predisposition to these infections. Early detection through this test can lead to more targeted and effective treatments, improving patient outcomes.
The test is available at DNA Labs UAE, a leading facility in genetic diagnostics. DNA Labs UAE employs state-of-the-art technology and adheres to the highest standards of accuracy and confidentiality. The cost of the IKBKG gene atypical mycobacterial infection genetic test is 4400 AED. This price reflects the comprehensive nature of the test, including the specialized techniques required to identify the genetic variations associated with susceptibility to atypical mycobacterial infections.
Patients or healthcare providers interested in this test can contact DNA Labs UAE for more information on the procedure, preparation, and any other requirements.
The IL12RB1 Gene Atypical Mycobacterial Infection Genetic Test is a specialized diagnostic tool designed to identify mutations in the IL12RB1 gene, which can predispose individuals to infections by atypical mycobacteria. These infections can be particularly severe and recurrent in individuals with compromised IL12RB1 function, making early detection crucial for effective management and treatment. The test involves analyzing the patient's DNA to look for abnormalities in the IL12RB1 gene that could impair the immune response to these pathogens.
Performed at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures high accuracy and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to conduct this specialized genetic analysis. By identifying genetic susceptibility to atypical mycobacterial infections, this test plays a critical role in guiding clinical decisions, including preventative measures, tailored treatments, and family planning advice for affected individuals.
